OMV Aktiengesellschaft (0MKH)
London Exchange · UK · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 73.40 |
|---|---|
| 52-week range | 45.10 – 74.55 |
| Return, 1 month / 3 months | +3.7% / +15.1% |
| Return, 1 year / 3 years | +70.2% / +102.8% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 21.8% |
| Worst drawdown (1 year) | -11.2% |
| Average daily value traded | 2.34M EUR |
| Dividend yield | 4.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
OMV Aktiengesellschaft is an integrated oil and gas company based in Vienna, Austria. It explores for and produces crude oil and natural gas, operates refineries that turn crude into fuels and petrochemical feedstocks, and runs a network of filling stations serving motorists and commercial customers, chiefly across Central and Eastern Europe. It also supplies natural gas to customers and produces base chemicals and plastics through its petrochemical operations, serving industrial and retail markets.
The shares are listed on the London Exchange in UK under the code 0MKH, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
OMV Aktiengesellschaft (0MKH) trades on the London Exchange in UK. It last closed at EUR 73.40 on 22 October 2026.
Its price-based Market X-Ray is 82 out of 100 (a strong price profile), ranking 27 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 70.2% and over the last three months it rose 15.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 23.0% | ||
| From 52-week high | -1.4% | ||
| Momentum | 89 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 15.1% | ||
| 6-month return | 33.4% | ||
| 12-month return, skipping the last month | 64.0% | ||
| Stability (higher is calmer) | 88 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -11.2% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.34M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +3.7% |
| 3 months | +15.1% |
| 6 months | +33.4% |
| 1 year | +70.2% |
| 3 years | +102.8% |
| 5 years | +86.7% |
Signals
| 50-day / 200-day average | 70.71 / 59.69 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.21 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Jun 2026 | EUR 3.1500 |
| 4 Jun 2025 | EUR 1.7000 |
| 5 Jun 2024 | EUR 2.9500 |
| 6 Jun 2023 | EUR 5.0500 |
| 10 Jun 2022 | EUR 2.3000 |
| 9 Jun 2021 | EUR 1.8500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.